Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Impacts of a smoking cessation benefit among employed populations.
Halpern MT, Dirani R, Schmier JK. Halpern MT, et al. Among authors: dirani r. J Occup Environ Med. 2007 Jan;49(1):11-21. doi: 10.1097/JOM.0b013e31802db579. J Occup Environ Med. 2007. PMID: 17215709
The cost effectiveness of varenicline for smoking cessation.
Halpern MT, Dirani R, Schmier JK. Halpern MT, et al. Among authors: dirani r. Manag Care Interface. 2007 Oct;20(10):18-25. Manag Care Interface. 2007. PMID: 18405203
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation.
Jackson KC 2nd, Nahoopii R, Said Q, Dirani R, Brixner D. Jackson KC 2nd, et al. Among authors: dirani r. J Occup Environ Med. 2007 Apr;49(4):453-60. doi: 10.1097/JOM.0b013e3180459ff2. J Occup Environ Med. 2007. PMID: 17426529 Clinical Trial.
Effect of smoking status on productivity loss.
Bunn WB 3rd, Stave GM, Downs KE, Alvir JM, Dirani R. Bunn WB 3rd, et al. Among authors: dirani r. J Occup Environ Med. 2006 Oct;48(10):1099-108. doi: 10.1097/01.jom.0000243406.08419.74. J Occup Environ Med. 2006. PMID: 17033509
Smoking cessation: the value of a comprehensive carved-in benefit.
Johnston SS, Mark TL, Dirani R. Johnston SS, et al. Among authors: dirani r. Am J Health Promot. 2008 Nov-Dec;23(2):85-7, ii. doi: 10.4278/ajhp.07091499. Am J Health Promot. 2008. PMID: 19004155
Indirect costs associated with nonadherence to treatment for bipolar disorder.
Bagalman E, Yu-Isenberg KS, Durden E, Crivera C, Dirani R, Bunn WB 3rd. Bagalman E, et al. Among authors: dirani r. J Occup Environ Med. 2010 May;52(5):478-85. doi: 10.1097/JOM.0b013e3181db811d. J Occup Environ Med. 2010. PMID: 20431414
The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J, Boulanger L, Marton J, Guadagno L, Dastani H, Dirani R, Phillips A, Shah H. Menzin J, et al. Among authors: dirani r. Respir Med. 2008 Sep;102(9):1248-56. doi: 10.1016/j.rmed.2008.04.009. Epub 2008 Jul 11. Respir Med. 2008. PMID: 18620852
Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians' perceptions of adherence vs. pharmacy claims.
Stephenson JJ, Tunceli O, Gu T, Eisenberg D, Panish J, Crivera C, Dirani R. Stephenson JJ, et al. Among authors: dirani r. Int J Clin Pract. 2012 Jun;66(6):565-73. doi: 10.1111/j.1742-1241.2012.02918.x. Epub 2012 May 11. Int J Clin Pract. 2012. PMID: 22574724 Free PMC article.
Do strict formularies replicate failure for patients with schizophrenia?
Goldman DP, Dirani R, Fastenau J, Conrad RM. Goldman DP, et al. Among authors: dirani r. Am J Manag Care. 2014 Mar;20(3):219-28. Am J Manag Care. 2014. PMID: 24884751 Free article.
Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics.
Vogt WB, Joyce G, Xia J, Dirani R, Wan G, Goldman DP. Vogt WB, et al. Among authors: dirani r. Health Aff (Millwood). 2011 Dec;30(12):2346-54. doi: 10.1377/hlthaff.2010.1296. Health Aff (Millwood). 2011. PMID: 22147863 Free PMC article.
45 results
Jump to page
Feedback